Imunon, Inc. Additional Paid in Capital, Common Stock
Imunon, Inc. (IMNN) had Additional Paid in Capital, Common Stock of $302.70 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2019-11-14
- 2019-09-30: Additional Paid in Capital, Common Stock $302.70M.
- 2019-06-30: Additional Paid in Capital, Common Stock $300.55M.
- 2019-03-31: Additional Paid in Capital, Common Stock $297.23M.
- 2018-12-31: Additional Paid in Capital, Common Stock $294.39M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2019-09-30 | $302.70M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $300.55M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $297.23M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $294.39M 10-Q · filed 2019-11-14 | |
| 2018-09-30 | $294.16M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $293.55M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $289.81M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $288.41M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $262.39M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $258.10M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $252.18M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $248.17M 10-K · filed 2018-03-27 | $247.88M 10-K · filed 2017-03-24 |
| 2016-09-30 | $246.40M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $245.97M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $240.28M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $239.67M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $238.86M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $238.64M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $230.63M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $229.78M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $229.45M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $228.94M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $217.54M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $203.14M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $197.08M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $190.96M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $190.74M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $170.96M 10-K · filed 2014-03-13 | $165.28M 10-K · filed 2013-03-18 |
| 2012-09-30 | $158.12M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $153.87M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $153.53M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $153.24M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $139.14M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $114.96M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $99.32M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |